News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1062 results

FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

US24-01-2023Muireann Bolger

Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.

Jazz Pharma’s medical cannabis unit seeks to block generic

US19-01-2023Liz Hockley

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.

Third Circuit backs pharma firm in antitrust clash

US13-12-2022Staff Writer

Years-long dispute centred on treatment for gastroesophageal reflux disease | Case invited questions concerning Noerr-Pennington doctrine and immunity | Takeda | Zydus.

Voluntary licensing opens up HIV treatment to 100 countries

Belarus, Switzerland06-12-2022Staff Writer

Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees.

Amarin appeals ‘skinny label’ loss

US23-11-2022Staff Writer

Generic heart drug was found to not infringe Amarin’s blockbuster treatment earlier this year | Health insurer Health Net tied to case after allegedly promoting use of the generic.

Big pharma steps up access, but uneven progress made: report

Netherlands16-11-2022Staff Writer

Licensing of COVID-19 treatments has shifted to include other medicines and treatment areas | World’s largest pharma companies still “consistently overlook the poorest countries” | Report offers strategy to improve access.

SCOTUS rejects BMS vs Gilead patent clash

US10-11-2022Staff Writer

Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices.

SCOTUS agrees to hear Amgen revival bid

US07-11-2022Staff Writer

The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.

Pharma firm voluntarily licences cancer drug in novel deal

01-11-2022

Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers

MSD hit with €39m fine over contraceptive generic delay

Spain26-10-2022Staff Writer

The probe in Spain centred on the delayed entry of generic versions of a branded contraceptive | The commission found evidence of “unjustified legal action”.

Showing 1 to 10 of 1062 results

LSIPR